Abstract:A number of multiresistant pathogens including Acinetobacter baumannii (A. baumannii) place a heavy burden on ventilator-associated pneumonia (VAP) patients in intensive care units (ICU). It is critically important to differentiate between bacterial infection and colonization to avoid prescribing unnecessary antibiotics. Quantitative culture of lower respiratory tract (LRT) specimens, however, requires invasive procedures. Nowadays, volatile organic compounds (VOCs) have been studied in vitro and in vivo to identify pathogen-derived biomarkers. Therefore, an exploratory pilot study was conceived for a proof of concept that the appearance and level of A. baumannii-derived metabolites might be correlated with the presence of the pathogen and its ecological niche (i.e. the infection and colonization states) in ICU ventilated patients. Twenty patients with A. baumannii VAP (infection group), 20 ventilated patients with LRT A. baumannii colonization (colonization group) and 20 ventilated patients with neurological disorders, but without pneumonia or A. baumannii colonization (control group) were enrolled in the in vivo pilot study. A clinical isolate of A. baumannii strains was used for the in vitro culture experiment. The adsorptive preconcentration (solid-phase microextraction fiber and Tenax(®) TA) and analysis technique of gas chromatography-mass spectrometry were applied in the studies. Breath profiles could be visually differentiated between A. baumannii cultivation in vitro and culture medium, and among in vivo groups. In the in vitro experiment, nine compounds of interest (2,5-dimethyl-pyrazine, 1-undecene, isopentyl 3-methylbutanoate, decanal, 1,3-naphthalenediol, longifolene, tetradecane, iminodibenzyl and 3-methyl-indene) in the headspace were found to be possible A. baumannii derivations. While there were eight target VOCs (1-undecene, nonanal, decanal, 2,6,10-trimethyl-dodecane, 5-methyl-5-propyl-nonane, longifolene, tetradecane and 2-butyl-1-octanol) exhibiting characteristics of A. baumannii VAP derivations. The selected VOC profile in vivo could be adopted to efficiently differentiate the presence of LRT A. baumannii from its absence, and LRT A. baumannii infection from its colonization (AUC = 0.89 and 0.88, respectively). It is not feasible to simply transfer the metabolic biomarkers from the in vitro condition to in vivo. The direct detection of exhaled A. baumannii-derived VOCs may be adopted for an early alert of the LRT bacterial presence in ventilated ICU patients, and even in different parasitic states of A. baumannii (i.e. infection and colonization). However, further refinement and validation are required before its clinical use.

Molecular Quantification of Pseudomonas Aeruginosa from Respiratory Samples in Patients with Suspected Ventilator Associated Pneumonia

Impact Clinically Related Factors on the Outcomes of Ventilator-Associated Pneumonia

Microbial Investigations in Throat Swab and Tracheal Aspirate Specimens Are Beneficial to Predict the Corresponding Endotracheal Tube Biofilm Flora among Intubated Neonates with Ventilator-Associated Pneumonia

Pathogenic analysis of sputum from ventilator-associated pneumonia in a pediatric intensive care unit.

Breath Analysis for Noninvasively Differentiating Acinetobacter Baumannii Ventilator-Associated Pneumonia from Its Respiratory Tract Colonization of Ventilated Patients

PCR Coupled to Electrospray Ionization Mass Spectrometry for Microbiological Diagnosis and Surveillance of Ventilator-Associated Pneumonia.

Droplet Digital PCR for Acinetobacter baumannii Diagnosis in Bronchoalveolar Lavage Samples from Patients with Ventilator-Associated Pneumonia

Exploring Ventilator-Associated Pneumonia: Microbial Clues and Biomarker Insights from a Retrospective Study

Evaluation of GeneXpert PA assay compared to genomic and (semi-)quantitative culture methods for direct detection of Pseudomonas aeruginosa in endotracheal aspirates

Early and specific targeted mass spectrometry-based identification of bacteria in endotracheal aspirates of patients suspected with ventilator-associated pneumonia

Evaluation of Five Host Inflammatory Biomarkers in Early Diagnosis of Ventilator-Associated Pneumonia in Critically Ill Children: A Prospective Single Center Cohort Study

Qualitative and quantitative rapid detection of VOCs differentially released by VAP-associated bacteria using PTR-MS and FGC-PTR-MS

Determination of Nasal and Endotracheal (ETT) Microorganisms in Pediatric Patients with Intubated VAP Admitted to the Pediatric Intensive Care Unit (PICU)

Plasminogen Activation Inhibitor Concentrations in Bronchoalveolar Lavage Fluid Distinguishes Ventilator-Associated Pneumonia from Colonization in Mechanically Ventilated Pediatric Patients

Rapid Identification of Pathogens Associated with Ventilator-Associated Pneumonia by Nanopore Sequencing

Incidence of Ventilator-Associated Pneumonia and its Bacterial Characterization – Intervention Based Prospective Study

Rapid Screen for Ventilator Associated Pneumonia Using Exhaled Volatile Organic Compounds

Ventilator associated pneumonia (VAP) in children: a diagnostic challenge

Prospective study of colonization and infection because of Pseudomonas aeruginosa in mechanically ventilated patients at a neonatal intensive care unit in China.

The Value of Polymerase Chain Reaction Assay in Ventilator-Associated Pneumonia in Children Undergoing Congenital Heart Disease Operation

Antibiotic Susceptibility and Genotype Patterns of Pseudomonas Aeruginosa from Mechanical Ventilation-Associated Pneumonia in Intensive Care Units.